HOME >> BIOLOGY >> NEWS
Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels

Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).

According to a new study published in the August 15, 2004 issue of the journal Cancer Research, administration of cannabinoids significantly lowered VEGF activity in laboratory mice and two patients with late-stage glioblastoma.

"Blockade of the VEGF pathway constitutes one of the most promising antitumoral approaches currently available," said Manuel Guzmn, professor of biochemistry and molecular biology, with the Complutense University in Madrid, Spain, and the study's principal investigator.

"The present findings provide a novel pharmacological target for cannabinoid-based therapies."

Glioblastoma multiforme, the most aggressive form of glioma, strikes more than 7,000 Americans each year and is considered one of the most malignant and deadliest forms of cancer, generally resulting in death within one to two years following diagnosis.

The disease is usually treated with surgery, followed by conventional radiation alone or in combination with chemotherapy. However, the main tumor often evades total destruction, surviving and growing again, eventually killing the patient. For this reason, researchers are actively seeking other therapeutic strategies, some of which might be considered novel.

In this study, the investigators chose to work with cannabinoids which, in previous studies, have been shown to inhibit the growth of blood vessels, or angiogenesis, in laboratory mice. However, little was known about the specific mechanisms by which cannabinoids impair angiogenesis, or whether the chemical might do the same in human tumors.

To answer the first part of the question, the scientists induced gliomas in mice, which were subsequently inoculated with cannabinoids. Using DNA array analysis, the tea
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
15-Aug-2004


Page: 1 2

Related biology news :

1. Marijuana use could cause tubal pregnancies
2. Marijuana receptor gene abnormality in schizophrenia
3. Study: Emission of smog ingredients from trees is increasing rapidly
4. New software developed at Rensselaer predicts promising ingredients for new drugs
5. Zengens new technology first to deliver drug active ingredients in an oral strip
6. Combining key ingredients of vegetarian diet cuts cholesterol significantly, says study
7. UCB-Bioproducts to provide active pharmaceutical ingredient for FDA approved angiomax (bivalirudin)
8. Scientists discover key ingredient in sexual reproduction
9. The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany
10. Inhibition of cathepsin proteases inhibits tumor formation in transgenic mice
11. Obesity drug inhibits prostate tumor growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... , ... Shoreline Biome , a microbiome research company that develops tools ... will debut a novel new DNA isolation kit at the Miami Winter Symposium ... Prep kit, is a fast and easy-to-use kit designed for the efficient and unbiased ...
(Date:1/23/2020)... ... , ... GIOSTAR/HEAMGEN has developed and secured patented ... red blood cells are made utilizing a bioreactor that permits the production of ... the need for a human blood donor. GIOSTAR/HEAMGEN mature red blood ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... cold chain operations, developing transport validation strategies, supporting global regulatory applications, and ... 5000 and the Houston Business Journal as a fastest growing company, and ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... ... solutions services in North America, today announced that the City of Fort Worth ... its biosolids management needs. Commencing in April of 2020, Synagro will assume operation ...
(Date:2/3/2020)... ... February 03, 2020 , ... ... Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , ... Index illustrates the following statistics:, Average airfare price ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... ... 24, 2020 , ... The impact of new medicines, procedures, ... and clinical services during the first two decades of the 21st century have ... Slone Partners celebrates its 20th anniversary this year, its evolution as a ...
Breaking Biology Technology:
Cached News: